Ivermectin and Fenbendazole for Psoriasis: 13 Case Reports (2025)
More than a superficial skin condition, psoriasis is a chronic condition of your immune system that triggers cells to build up on the surface of your skin. This leads to thick, scaly and red patches that itch and are sometimes painful. Psoriasis is a prevalent chronic autoimmune dermatosis affecting approximately 2-3% of the global population, characterized by erythematous, scaly plaques resulting from dysregulated keratinocyte proliferation and T-cell-mediated inflammation. While psoriasis is an inflammatory response, it can lead to an infection if you frequently scratch the affected areas. In the United States alone, it impacts over 7.5 million individuals (1), imposing substantial economic burdens estimated at $112 billion annually, while increasing risks for comorbidities such as psoriatic arthritis, cardiovascular disease, diabetes, and depression (with depression rates up to 50% in affected patients). Current therapies, including topical corticosteroids, phototherapy, and bi...